Condition: Cancer · Exercise · Implementation · Sponsor: University Hospital Heidelberg
MOVE-ONKO is developing and implementing a guideline-based, multi-professional care pathway for the promotion and therapy of exercise for cancer patients. This pathway intended to serve as an interface between oncological care and existing or developing exercise therapy services in the local area of the participating hospitals. Needs- and side-effect-oriented care pathways are intended to give as many patients as possible access to quality-assured exercise therapy services close to home and thus to the supportive potential of exercise. The new care pathway will be develop in year 1 (phase 1) and will be established at 7 Comprehensive Cancer Centers (CCCs) in 3 model regions Heidelberg-Frankfurt-Mainz, Dresden-Berlin and Freiburg-Tübingen (phase 2) in Germany, as well as adapted accordingly in organ cancer centers and with established oncological care providers (phase 3 - Outreach). The aim is to ensure that exercise promotion and therapy can be integrated into standard care as comprehensively and sustainably as possible. The implementation project will be evaluated according to the achievement of implementation and intervention goals. The implementation goals are utilization (reach) and actual implementation. Factors for successful implementation will be identified and incorporated into the procedure in phase 3 (outreach). Intervention goals are mapped at provider and patient level in both phases. They include improving physical functioning, increasing physical activity beha…
This description comes directly from the study's public registry record.
Joachim Wiskemann, Prof · +49 6221 565904 · joachim.wiskemann@nct-heidelberg.de
Julia Albrecht, Dr · +49 6221 56-32630 · julia.albrecht@nct-heidelberg.de
Always discuss trial participation with your own doctor first.
| Universitätsklinikum Freiburg | Freiburg im Breisgau, Baden-Wurttemberg, Germany | Recruiting |
| Nationales Centrum für Tumorerkrankungen | Heidelberg, Baden-Wurttemberg, Germany | Recruiting |
| Medizinische Klinik der Universitätsklinikum Tübingen | Tübingen, Baden-Wurttemberg, Germany | Recruiting |
| Universitäres Centrum für Tumorekrankungen Frankfurt | Frankfurt am Main, Hesse, Germany | Recruiting |
| Universitäres Centrum für Tumorerkrankungen Mainz | Mainz, Rhineland-Palatinate, Germany | Recruiting |
| Nationales Centrum für Tumorerkrankungen Dresden (NCT/UCC) | Dresden, Saxony, Germany | Recruiting |
| Charité - Universitätsmedizin Berlin | Berlin, State of Berlin, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06185777